🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Impressive review by Valentina Tateo

Ready for tomorrow for the 1st International ARON Meeting ARON project Matteo Santoni Javier Molina Cerrillo

Thrilled to Participat 🇦🇷 in 1st ARON project meeting. Great colaborative group. Fernando Sabino, MD, PhD FLoscoMD Juan Pablo Sade Dr. Tomás Soulé Instituto Alexander Fleming Fundación Cáncer

🌟Excited and honored to be part of the 1st International ARON Meeting! Ready to keep learning, sharing, and growing together! Thanks for the kind invitation ARON project Matteo Santoni Javier Molina Cerrillo Let’s shape the future of #GUoncology together! OncoAlert #ARONMeeting

1st International ARON Meeting.  An impressive moment of discussion full of ideas between brilliant professionals and friends. Thanks to the ARON project and to Matteo Santoni for the precious support. Let's keep dreaming and see you at the next appointment at ESMO - Eur. Oncology

The ARON project

Congrats Matteo Santoni and Francesco Massari 4 ARON project – you made the unimaginable happen!🎆Bringing together people from all over the world🌍,united by passion and the drive to answer important questions. Proud to have been part of it OncoDaily IBCG associazionepalinuro

L’ultima di un’annata tutt’altro che spensierata. Fallo per chi c’è sempre stato, per chi c’è e per chi comunque sempre ci sarà ..  “Fate come noi.. Non mollate mai”

A chi c’è sempre stato. A chi comunque sempre ci sarà.

Proud to Be Part of the ARON project That Made the Unimaginable Happen - Patrizia Giannatempo (Patrizia Giannatempo) Matteo Santoni Francesco Massari oncodaily.com/blog/aron-proj… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ARON CancerWorld

🔬 In the TheraP trial for mCRPC, ctDNA unlocks new biomarker insights for [¹⁷⁷Lu]Lu–PSMA-617! 🧪 180 PSMA PET-selected pts, 290 cfDNA samples analyzed 🔹 Low ctDNA = 🔥 better PSA50 response (100% vs 58%) 🕒 PFS boost: 14.7 vs 6.0 mo (HR 0.12) — independent of PET! 🧬 PTEN

Pembro/Axi vs. Nivo/Cabo as first-line therapy in mRCC patients. Out now another important experience by ARON project OncoDaily IKCC Kidney Cancer Kidney Cancer

Brilliant summary from Tom Powles ahead of #ASCO25

E tu dove andrai pagliaccio 🤡

Francesco Massari ARON project IKCC Kidney Cancer Kidney Cancer Matteo Santoni Enrique Grande Javier Molina Cerrillo Sebastiano Buti Giandomenico Roviello We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/science/aron-p…

Thanks to Maite Bourlon for presenting ARON project at #ASCO2025 Oncoinfo OncoDaily ESMO - Eur. Oncology

Francesco Massari Maite Bourlon ARON project Oncoinfo ESMO - Eur. Oncology Matteo Santoni We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/blog/maite-bou…

The 5 yr follow up for adjuvant pembro in RCC (KN564): continued benefit- DFS (5yr 52% v61% - HR0.71) OS (5yr 82% vs 88% HR0.66). Maintained KM curve separation. No subgroup stands out. 18% TRAEs. Long term tox difficult to quantify but benifits seem to outweigh risks #ASCO25

Ops we did it again